ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/06/15 | 1,526 | 1,589 | 1,509 | 1,588 | +64 | +4.2% | 349,900 |
2017/06/14 | 1,531 | 1,545 | 1,506 | 1,524 | -8 | -0.5% | 74,700 |
2017/06/13 | 1,481 | 1,534 | 1,481 | 1,532 | +53 | +3.6% | 156,400 |
2017/06/12 | 1,492 | 1,510 | 1,474 | 1,479 | -3 | -0.2% | 109,600 |
2017/06/09 | 1,487 | 1,495 | 1,475 | 1,482 | -3 | -0.2% | 55,100 |
2017/06/08 | 1,494 | 1,500 | 1,470 | 1,485 | +5 | +0.3% | 42,600 |
2017/06/07 | 1,475 | 1,498 | 1,469 | 1,480 | -1 | -0.1% | 85,900 |
2017/06/06 | 1,500 | 1,500 | 1,481 | 1,481 | -21 | -1.4% | 94,200 |
2017/06/05 | 1,537 | 1,538 | 1,500 | 1,502 | -14 | -0.9% | 122,500 |
2017/06/02 | 1,522 | 1,533 | 1,516 | 1,516 | +1 | +0.1% | 43,700 |
2017/06/01 | 1,505 | 1,518 | 1,500 | 1,515 | +5 | +0.3% | 50,100 |
2017/05/31 | 1,511 | 1,538 | 1,507 | 1,510 | -5 | -0.3% | 38,500 |
2017/05/30 | 1,528 | 1,550 | 1,507 | 1,515 | -39 | -2.5% | 97,800 |
2017/05/29 | 1,568 | 1,580 | 1,502 | 1,554 | -3 | -0.2% | 62,500 |
2017/05/26 | 1,588 | 1,588 | 1,553 | 1,557 | -18 | -1.1% | 32,100 |
2017/05/25 | 1,549 | 1,580 | 1,528 | 1,575 | +27 | +1.7% | 62,300 |
2017/05/24 | 1,562 | 1,571 | 1,524 | 1,548 | -20 | -1.3% | 80,600 |
2017/05/23 | 1,570 | 1,590 | 1,558 | 1,568 | -2 | -0.1% | 22,700 |
2017/05/22 | 1,606 | 1,606 | 1,570 | 1,570 | -27 | -1.7% | 45,600 |
2017/05/19 | 1,614 | 1,623 | 1,581 | 1,597 | -53 | -3.2% | 94,100 |
2017/05/18 | 1,550 | 1,660 | 1,534 | 1,650 | +31 | +1.9% | 107,600 |
2017/05/17 | 1,640 | 1,640 | 1,601 | 1,619 | -24 | -1.5% | 54,500 |
2017/05/16 | 1,653 | 1,657 | 1,641 | 1,643 | -3 | -0.2% | 27,700 |
2017/05/15 | 1,669 | 1,670 | 1,646 | 1,646 | -7 | -0.4% | 31,300 |
2017/05/12 | 1,652 | 1,668 | 1,651 | 1,653 | +2 | +0.1% | 19,100 |
2017/05/11 | 1,695 | 1,698 | 1,650 | 1,651 | -43 | -2.5% | 70,200 |
2017/05/10 | 1,680 | 1,735 | 1,680 | 1,694 | +14 | +0.8% | 117,800 |
2017/05/09 | 1,699 | 1,717 | 1,680 | 1,680 | -19 | -1.1% | 56,900 |
2017/05/08 | 1,684 | 1,701 | 1,676 | 1,699 | +24 | +1.4% | 62,100 |
2017/05/02 | 1,680 | 1,681 | 1,665 | 1,675 | +10 | +0.6% | 29,700 |
2017/05/01 | 1,678 | 1,690 | 1,651 | 1,665 | -9 | -0.5% | 23,500 |
2017/04/28 | 1,665 | 1,676 | 1,651 | 1,674 | +8 | +0.5% | 23,100 |
2017/04/27 | 1,647 | 1,670 | 1,645 | 1,666 | +11 | +0.7% | 30,600 |
2017/04/26 | 1,660 | 1,669 | 1,648 | 1,655 | -6 | -0.4% | 42,300 |
2017/04/25 | 1,645 | 1,701 | 1,621 | 1,661 | +10 | +0.6% | 47,800 |
2017/04/24 | 1,701 | 1,709 | 1,643 | 1,651 | -74 | -4.3% | 84,900 |
2017/04/21 | 1,683 | 1,746 | 1,670 | 1,725 | +72 | +4.4% | 105,300 |
2017/04/20 | 1,652 | 1,661 | 1,624 | 1,653 | +1 | +0.1% | 21,300 |
2017/04/19 | 1,610 | 1,657 | 1,610 | 1,652 | +2 | +0.1% | 26,900 |
2017/04/18 | 1,598 | 1,650 | 1,583 | 1,650 | +88 | +5.6% | 76,200 |
2017/04/17 | 1,515 | 1,626 | 1,501 | 1,562 | +17 | +1.1% | 34,700 |
2017/04/14 | 1,600 | 1,604 | 1,541 | 1,545 | -44 | -2.8% | 44,500 |
2017/04/13 | 1,430 | 1,650 | 1,430 | 1,589 | +65 | +4.3% | 139,800 |
2017/04/12 | 1,600 | 1,603 | 1,500 | 1,524 | -90 | -5.6% | 248,600 |
2017/04/11 | 1,630 | 1,630 | 1,601 | 1,614 | -40 | -2.4% | 114,100 |
2017/04/10 | 1,700 | 1,705 | 1,650 | 1,654 | -46 | -2.7% | 65,600 |
2017/04/07 | 1,702 | 1,716 | 1,638 | 1,700 | -20 | -1.2% | 100,400 |
2017/04/06 | 1,750 | 1,752 | 1,700 | 1,720 | -44 | -2.5% | 79,000 |
2017/04/05 | 1,751 | 1,770 | 1,739 | 1,764 | +13 | +0.7% | 35,700 |
2017/04/04 | 1,788 | 1,802 | 1,748 | 1,751 | -55 | -3% | 55,900 |
2001~
2050
件表示中 / 2491件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 57,300円 | +150.0% | - | 0.00% | - | 52.71倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
JCRファーマ | 62,900円 | +14.3% | - | 3.18% | 25.57倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 254,000円 | +16.9% | +33.2% | 2.17% | 13.87倍 | 1.10倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
クオリプス | 739,000円 | +237.1% | - | 0.00% | - | 11.01倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
タウンズ | 58,300円 | +11.5% | -0.9% | 4.80% | 6.98倍 | 3.45倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム